(Q37135356)

18 August 2017

1 reference

title

Detection, clinical relevance and specific biological properties of disseminating tumour cells (English)

1 reference

18 August 2017

Klaus Pantel

1

1 reference

18 August 2017

Ruud H Brakenhoff

series ordinal

2

1 reference

18 August 2017

Burkhard Brandt

series ordinal

3

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

18 August 2017

published in

Nature Reviews Cancer

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

5

1 reference

18 August 2017

page(s)

329-340

1 reference

Cancer incidence and mortality in Europe, 2004

18 August 2017

cites work

1 reference

Metastasis: recent discoveries and novel treatment strategies

31 March 2020

1 reference

Systemic spread is an early step in breast cancer

31 March 2020

1 reference

The clinical significance of circulating tumor cells

31 March 2020

1 reference

Dissecting the metastatic cascade

31 March 2020

1 reference

Circulating tumor cells in patients with breast cancer dormancy

31 March 2020

1 reference

Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity

31 March 2020

1 reference

Circulating tumor cells in breast cancer: Advanced tools for "tailored" therapy?

31 March 2020

1 reference

31 March 2020

1 reference

Circulating tumor cells (CTC) detection: clinical impact and future directions.

31 March 2020

1 reference

A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation

31 March 2020

1 reference

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

31 March 2020

1 reference

Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer

31 March 2020

1 reference

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

31 March 2020

1 reference

Global gene expression profiling of circulating tumor cells.

31 March 2020

1 reference

Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival

31 March 2020

1 reference

Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer

31 March 2020

1 reference

Circulating tumor cells predict survival in patients with metastatic prostate cancer

31 March 2020

1 reference

Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor

31 March 2020

1 reference

Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

31 March 2020

1 reference

Isolation of rare circulating tumour cells in cancer patients by microchip technology

31 March 2020

1 reference

Tumor-antigen heterogeneity of disseminated breast cancer cells: implications for immunotherapy of minimal residual disease

31 March 2020

1 reference

In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry

31 March 2020

1 reference

High speed detection of circulating tumor cells.

31 March 2020

1 reference

A rare-cell detector for cancer

31 March 2020

1 reference

Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells

31 March 2020

1 reference

Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection

31 March 2020

1 reference

Current status in human breast cancer micrometastasis

31 March 2020

1 reference

Detection and characterization of putative metastatic precursor cells in cancer patients

31 March 2020

1 reference

Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction

31 March 2020

1 reference

Detection of circulating tumour cells in blood by quantitative real-time RT-PCR: effect of pre-analytical time.

31 March 2020

1 reference

Quantification of mRNA using real-time RT-PCR

31 March 2020

1 reference

Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support.

31 March 2020

1 reference

Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers.

31 March 2020

1 reference

Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.

31 March 2020

1 reference

Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine

31 March 2020

1 reference

Development of a high-throughput membrane-array method for molecular diagnosis of circulating tumor cells in patients with gastric cancers.

31 March 2020

1 reference

CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor.

31 March 2020

1 reference

Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer

31 March 2020

1 reference

Multiple molecular markers as predictors of colorectal cancer in patients with normal perioperative serum carcinoembryonic antigen levels

31 March 2020

1 reference

Circulating tumor cells in perioperative esophageal cancer patients: quantitative assay system and potential clinical utility

31 March 2020

1 reference

How to improve the present TNM staging system

31 March 2020

1 reference

Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual

31 March 2020

1 reference

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

31 March 2020

1 reference

The clinical significance of disseminated tumor cells in breast cancer

31 March 2020

1 reference

A pooled analysis of bone marrow micrometastasis in breast cancer

31 March 2020

1 reference

Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase

31 March 2020

1 reference

Biological characteristics of micrometastatic cancer cells in bone marrow

31 March 2020

1 reference

Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells

31 March 2020

1 reference

Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients

31 March 2020

1 reference

Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer

31 March 2020

1 reference

Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer.

31 March 2020

1 reference

Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.

31 March 2020

1 reference

Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients

31 March 2020

1 reference

Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer

31 March 2020

1 reference

Detection and clinical implications of minimal residual disease in gastro-intestinal cancer

31 March 2020

1 reference

Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival

31 March 2020

1 reference

Survivin mRNA in peripheral blood is frequently detected and significantly decreased following resection of gastrointestinal cancers.

31 March 2020

1 reference

Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures

31 March 2020

1 reference

Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome

31 March 2020

1 reference

The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence

31 March 2020

1 reference

Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients

31 March 2020

1 reference

Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years.

31 March 2020

1 reference

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

31 March 2020

1 reference

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer

31 March 2020

1 reference

Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells

31 March 2020

1 reference

From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression

31 March 2020

1 reference

Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer

31 March 2020

1 reference

Genomic profiling of viable and proliferative micrometastatic cells from early-stage breast cancer patients

31 March 2020

1 reference

Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer

31 March 2020

1 reference

Evidence emerges for early metastasis and parallel evolution of primary and metastatic tumors

31 March 2020

1 reference

Asynchronous growth of prostate cancer is reflected by circulating tumor cells delivered from distinct, even small foci, harboring loss of heterozygosity of the PTEN gene.

31 March 2020

1 reference

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

31 March 2020

1 reference

High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity

31 March 2020

1 reference

Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.

31 March 2020

1 reference

Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors

31 March 2020

1 reference

Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer

31 March 2020

1 reference

Circulating breast cancer cells are frequently apoptotic

31 March 2020

1 reference

Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status

31 March 2020

1 reference

Frequent detection and immunophenotyping of prostate-derived cell clusters in the peripheral blood of prostate cancer patients.

31 March 2020

1 reference

HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients

31 March 2020

1 reference

HER-2 gene amplification can be acquired as breast cancer progresses

31 March 2020

1 reference

Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow

31 March 2020

1 reference

uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues

31 March 2020

1 reference

Models, mechanisms and clinical evidence for cancer dormancy

31 March 2020

1 reference

Adaptive immunity maintains occult cancer in an equilibrium state

31 March 2020

1 reference

Cancer stem cells and metastasis: lethal seeds

31 March 2020

1 reference

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

31 March 2020

1 reference

Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype

31 March 2020

1 reference

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

31 March 2020

1 reference

Prospective identification of tumorigenic breast cancer cells

31 March 2020

1 reference

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

31 March 2020

1 reference

Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients

31 March 2020

1 reference

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

31 March 2020

1 reference

Breast-Cancer Stromal Cells withTP53Mutations and Nodal Metastases

31 March 2020

1 reference

Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma

31 March 2020

1 reference

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

31 March 2020

1 reference

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

31 March 2020

1 reference

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

31 March 2020

1 reference

Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer

31 March 2020

1 reference

Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model

31 March 2020

1 reference

Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis.

31 March 2020

1 reference

Isolation of blood-borne epithelium-derived c-erbB-2 oncoprotein-positive clustered cells from the peripheral blood of breast cancer patients

31 March 2020

1 reference

Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy

31 March 2020

1 reference

Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients

31 March 2020

1 reference

Tumor metastasis: mechanistic insights and clinical challenges

31 March 2020

1 reference

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

31 March 2020

1 reference

Endogenous human microRNAs that suppress breast cancer metastasis

31 March 2020

1 reference

Host genetics influence tumour metastasis

31 March 2020

1 reference

Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes.

31 March 2020

1 reference

The relevance of RT-PCR detection of disseminated tumour cells is hampered by the expression of markers regarded as tumour-specific in activated lymphocytes.

31 March 2020

1 reference

Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients

31 March 2020

1 reference

Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients

31 March 2020

1 reference

Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance

31 March 2020

1 reference

c-erbB-2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cells

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRC2375

1 reference

Dimensions Publication ID

18 August 2017

1024437178

0 references

1 reference